Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117013) titled 'A Study on the Treatment of Primary Coronary Artery Vascular Lesions with Biolimus Coated Coronary Balloon Dilation Catheter' on Jan. 19.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The First Affiliated Hospital of Guangxi Medical University
Condition:
Primary coronary artery disease with a blood vessel diameter of 2.0mm-2.75mm
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2024-06-19
Target Sample Size: Biolimus coated Coronary Artery Balloon Dilation Catheter (BioAscend) Treatment Group:300;
Countries of Recruitment:
China
To know more, visit ht...